-
Founded in:
1998-01-23 -
Country:
China -
Address:
No. 158, Jinlong Road, Tonghua City -
Tax NO.:
91220501702230097Q -
Registered Funds:
40 million yuan -
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
723-46-6 | 33 | |
| Sulfadiazine |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
68-35-9 | 14 | |
| Trimethoprim |
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia.
More
The blood concentration of sulfa should not exceed 200 μg/ml. If it exceeds this concentration, the incidence of adverse reactions will increase and the toxicity will increase. Excessive short-term use of this product will cause loss of appetite, abdominal pain, nausea, vomiting, dizziness, headache, drowsiness, confusion, depression, fever, hematuria, crystalluria, blood diseases, jaundice, bone marrow suppression, etc. Long-term excessive use of this product will cause bone marrow suppression, resulting in a decrease in platelets and leukocytes and megaloblastic anemia. |
738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfamethoxazole |
It acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis. When used in combination with trimethoprim, it can double block bacterial folic acid metabolism and enhance the synergistic antibacterial effect. It has good antibacterial effect on a variety of bacteria.
More
It acts on dihydrofolate synthase, interfering with the first step of folic acid synthesis. When used in combination with trimethoprim, it can double block bacterial folic acid metabolism and enhance the synergistic antibacterial effect. It has good antibacterial effect on a variety of bacteria. |
723-46-6 | 33 | |
| Trimethoprim |
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and can double block bacterial folic acid metabolism when used in combination with sulfamethoxazole, enhancing the synergistic antibacterial effect. It has good antibacterial effect on a variety of bacteria.
More
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and can double block bacterial folic acid metabolism when used in combination with sulfamethoxazole, enhancing the synergistic antibacterial effect. It has good antibacterial effect on a variety of bacteria. |
738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Sulfadiazine |
It acts on dihydrofolate synthase, interfering with the first step in the synthesis of folic acid, and has a synergistic antibacterial effect when used in combination with trimethoprim.
More
It acts on dihydrofolate synthase, interfering with the first step in the synthesis of folic acid, and has a synergistic antibacterial effect when used in combination with trimethoprim. |
0.4g | 68-35-9 | 14 |
| Trimethoprim |
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and has a synergistic antibacterial effect when used in combination with sulfadiazine.
More
It acts on the second step of folic acid anabolism, selectively inhibits the action of dihydrofolate reductase, and has a synergistic antibacterial effect when used in combination with sulfadiazine. |
50mg | 738-70-5 | 44 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| LYSIMACHIAE HERBA |
|
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| L-Lysine hydrochloride |
Lysine is one of the eight essential amino acids that maintain the body's nitrogen balance. It can promote protein synthesis and metabolism, and has a role in promoting human growth and intellectual development.
More
Lysine is one of the eight essential amino acids that maintain the body's nitrogen balance. It can promote protein synthesis and metabolism, and has a role in promoting human growth and intellectual development. |
10098-89-2 | 16 | |
| Calcium phosphate dibasic |
Calcium ions are necessary to maintain the normal functions of nerves, muscles and bones; they can promote the calcification of bones and teeth. They also play an important role in maintaining normal heart, kidney, lung and coagulation functions, as well as cell and capillary permeability. In addition, calcium is also involved in regulating the secretion and storage of neurotransmitters and hormones, maintaining the normal excitability of nerves and muscles, as well as the intake and binding of amino acids, the absorption of vitamin B12, etc.
More
Calcium ions are necessary to maintain the normal functions of nerves, muscles and bones; they can promote the calcification of bones and teeth. They also play an important role in maintaining normal heart, kidney, lung and coagulation functions, as well as cell and capillary permeability. In addition, calcium is also involved in regulating the secretion and storage of neurotransmitters and hormones, maintaining the normal excitability of nerves and muscles, as well as the intake and binding of amino acids, the absorption of vitamin B12, etc. |
7757-93-9 | 14 |